diagnosis and treatment of infertility, first/second/third generation IVF (including
egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
disease
diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
clinical
technology applications. Many of these technologies are at the leading level both domestically
and
internationally.
1. What is corpus luteum support?
In assisted reproductive medicine, "luteal support" refers to supplementing or maintaining the progesterone level in the body through drug or hormone intervention before and after embryo transfer, thus providing a stable uterine environment for embryo implantation and early development.
From the first-principles point of view, whether an embryo can be successfully implanted essentially depends on two variables:
Embryo quality
Endometrial receptivity
And "corpus luteum support" just acts on the second variable-maintaining the endometrium in an acceptable state.
Medical research shows that in the natural cycle, lutein formed after ovulation secretes progesterone. However, in the IVF cycle, luteal function is often inhibited due to ovulation induction drugs, egg retrieval process and other factors, so exogenous supplementation is needed (source: American Society for Reproductive Medicine Guidelines Consensus).
Expert tip:
Luteal support is not a single means to "improve the success rate", but a necessary link to "make up for physical defects" and belongs to basic support measures.

2. Who needs corpus luteum support?
Clinically, almost all people who enter the IVF cycle will be involved in luteal support, but the key groups include:
Patients with ovulation induction cycle
After ovarian intervention with hormones, luteal function decreased.
Frozen embryo transfer patient (FET)
No natural ovulation, completely dependent on artificial hormone support.
Older women (≥35 years old)
Decreased luteal function is more common.
People who have failed to transplant repeatedly in the past
There may be endometrial receptivity problems.
Patients with luteal insufficiency (LPD)
The common clinical manifestation is progesterone deficiency.
The data show that in IVF cycle, if the corpus luteum support is not standardized, the implantation rate may decrease significantly (source: European Society of Human Reproduction and Embryology Guide Review).
Expert tip:
It is not "the higher the dose, the better". Luteal support emphasizes individualized programs and needs to be adjusted in combination with hormone level monitoring.
3. What technologies are involved in luteal support?
From the medical mechanism, corpus luteum support mainly revolves around "progesterone supplement", and the common ways include:
Vaginal administration (mainstream mode)
Common forms: gel, suppository
Advantages: high local concentration and obvious uterine targeting effect.
The frequency of clinical use is high
Intramuscular injection (progesterone injection)
Advantages: stable blood concentration.
Disadvantages: obvious pain and low compliance.
Oral drugs (such as dydrogesterone)
convenient to use
However, some studies believe that the bioavailability is slightly lower.
Joint programme
Vagina+oral or injection
Used for high-risk groups.
In some centers (including some assisted reproductive institutions in Central Asia), the following technologies may also be combined:
Estrogen supplement (improving intimal thickness)
Auxiliary stimulation of hCG (partial cycle)
Expert tip:
Progesterone is a "window hormone", and its action time is very critical. Once it is misplaced, it may affect the synchronization of implantation window.
Fourth, the specific process of corpus luteum support (process layer)
Taking the common IVF cycle as an example, corpus luteum support is generally divided into the following stages:
Start-up stage (after egg retrieval or ovulation)
Time point: the day after egg retrieval or the next day.
Start progesterone supplementation
Pretransplant maintenance
Continuous medication
Ensure that the endometrium enters the "implantation window"
Post-transplant reinforcement stage
Continuous supplementation after transplantation
Maintain embryo implantation environment
Pregnancy test stage (about 10-14 days after transplantation)
Detection of hCG level
Judge whether you are pregnant or not
Postpregnancy continuation
If the pregnancy is successful, continue to use it until 10–12 weeks of pregnancy.
Then gradually decrease.
Expert tip:
The common clinical misunderstanding is "stop taking medicine after a successful pregnancy test". In fact, the placenta has not completely taken over hormone secretion in the early stage, and stopping taking medicine prematurely may increase the risk.
V. Analysis of Frequently Asked Questions
Q1: Will luteal support affect embryo quality?
No.
Luteal support mainly acts on the endometrium, not the embryo itself.
Q2: Is it safer to take medicine for longer?
Not necessarily.
It needs to be gradually adjusted according to the gestational age and hormone level.
Q3: Does everyone need an injection?
No.
At present, vaginal administration has become a common choice, and whether to inject should be based on individual conditions.
Q4: What will happen if luteal support fails?
Intima instability
Implantation failure
Increased risk of early abortion
Q5: Is there any difference between overseas test tubes (such as Kyrgyzstan) and domestic ones?
The overall medical principles are consistent, but there may be differences in the following aspects:
Individualized degree of medication regimen
Drug selection range
Follow-up and monitoring methods
Expert tip:
The differences between different countries are mainly reflected in "management mode" and "implementation details", rather than core medical principles.
VI. Summary
Summarize the core points:
Luteal support is the basic link in IVF cycle.
The core function is to maintain the endometrium suitable for embryo implantation.
Mainly through progesterone supplementation.
Almost all IVF patients need it
The medication regimen needs to be adjusted individually.
From the medical logic point of view, corpus luteum support is not a "single point factor that determines success or failure", but a "basic stabilizer" in the whole test tube process. Its function is similar to "soil improvement", providing a more acceptable growth environment for embryos.
🏥 Located in downtown Bishkek, the capital of Kyrgyzstan, near the National Museum and Victory Square. It is the first Chinese-invested, officially licensed assisted reproductive hospital in the country. Founded and directly operated by Mr. Chen Yinuo (EnoChan), the center specializes in high-level fertility services including PGT (3rd generation IVF) and legal third-party reproduction for global clients, especially Chinese patients.
🌷 Technology-Assisted Fertility, Fulfilling Dreams · Patience · Integrity · Professionalism

